Witnessing the stock’s movement on the chart, on Thursday, Kezar Life Sciences Inc (NASDAQ: KZR) had a quiet start as it plunged -3.02% to $4.17, before settling in for the price of $4.3 at the close. Taking a more long-term approach, KZR posted a 52-week range of $3.53-$8.95.
It was noted that the giant of the Healthcare sector posted annual sales growth of 8.98% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 8.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 28.12%. This publicly-traded company’s shares outstanding now amounts to $7.32 million, simultaneously with a float of $6.24 million. The organization now has a market capitalization sitting at $30.54 million. At the time of writing, stock’s 50-day Moving Average stood at $3.95, while the 200-day Moving Average is $4.78.
Kezar Life Sciences Inc (KZR) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Kezar Life Sciences Inc’s current insider ownership accounts for 14.82%, in contrast to 60.18% institutional ownership. According to the most recent insider trade that took place on Jul 02 ’25, this organization’s SVP, Corporate Controller sold 264 shares at the rate of 4.28, making the entire transaction reach 1,130 in total value, affecting insider ownership by 2,711. Preceding that transaction, on Jul 02 ’25, Company’s Chief Operating Officer sold 561 for 4.28, making the whole transaction’s value amount to 2,401. This particular insider is now the holder of 2,739 in total.
Kezar Life Sciences Inc (KZR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.69 per share during the current fiscal year.
Kezar Life Sciences Inc’s EPS increase for this current 12-month fiscal period is 28.12% and is forecasted to reach -4.97 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 26.86% through the next 5 years, which can be compared against the 8.98% growth it accomplished over the previous five years trading on the market.
In the same vein, KZR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.69, a figure that is expected to reach -2.16 in the next quarter, and analysts are predicting that it will be -4.97 at the market close of one year from today.
Technical Analysis of Kezar Life Sciences Inc (KZR)
Going through the that latest performance of [Kezar Life Sciences Inc, KZR]. Its last 5-days volume of 0.38 million indicated improvement to the volume of 47818.0 it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 66.26% While, its Average True Range was 55.28.
Raw Stochastic average of Kezar Life Sciences Inc (KZR) in the period of the previous 100 days is set at 43.41%, which indicates a major fall in contrast to 57.53% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.29 that was higher than 0.22 volatility it exhibited in the past 100-days period.
